Literature DB >> 25349384

Mathematical model of sarcoidosis.

Wenrui Hao1, Elliott D Crouser2, Avner Friedman3.   

Abstract

Sarcoidosis is a disease involving abnormal collection of inflammatory cells forming nodules, called granulomas. Such granulomas occur in the lung and the mediastinal lymph nodes, in the heart, and in other vital and nonvital organs. The origin of the disease is unknown, and there are only limited clinical data on lung tissue of patients. No current model of sarcoidosis exists. In this paper we develop a mathematical model on the dynamics of the disease in the lung and use patients' lung tissue data to validate the model. The model is used to explore potential treatments.

Entities:  

Keywords:  granuloma; math modeling; sarcoidosis

Mesh:

Year:  2014        PMID: 25349384      PMCID: PMC4234561          DOI: 10.1073/pnas.1417789111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.

Authors:  F Idali; M Wikén; J Wahlström; H Mellstedt; A Eklund; H Rabbani; J Grunewald
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

2.  Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.

Authors:  A Hancock; L Armstrong; R Gama; A Millar
Journal:  Am J Respir Cell Mol Biol       Date:  1998-01       Impact factor: 6.914

3.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

4.  Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.

Authors:  B Galve-de Rochemonteix; L P Nicod; J M Dayer
Journal:  Am J Respir Cell Mol Biol       Date:  1996-03       Impact factor: 6.914

5.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

6.  TGF-beta promotes Th17 cell development through inhibition of SOCS3.

Authors:  Hongwei Qin; Lanfang Wang; Ting Feng; Charles O Elson; Sandrine A Niyongere; Sun Jung Lee; Stephanie L Reynolds; Casey T Weaver; Kevin Roarty; Rosa Serra; Etty N Benveniste; Yingzi Cong
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

7.  Racial differences in sarcoidosis granuloma density.

Authors:  Robert R Burke; Chad H Stone; Suzanne Havstad; Benjamin A Rybicki
Journal:  Lung       Date:  2008-08-21       Impact factor: 2.584

8.  Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.

Authors:  Jenny L McGovern; Dao X Nguyen; Clare A Notley; Claudia Mauri; David A Isenberg; Michael R Ehrenstein
Journal:  Arthritis Rheum       Date:  2012-10

9.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

10.  Synergistic Induction of Macrophage Inflammatory Protein-3α;/CCL20 Production by Interleukin-17A and Tumor Necrosis Factor-α; in Nasal Polyp Fibroblasts.

Authors:  Manabu Nonaka; Nozomu Ogihara; Akira Fukumoto; Atsuko Sakanushi; Kaoru Kusama; Ruby Pawankar; Toshiaki Yagi
Journal:  World Allergy Organ J       Date:  2009-10       Impact factor: 4.084

View more
  17 in total

Review 1.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

2.  Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.

Authors:  Audrey Melin; Émilie Routier; Séverine Roy; Pauline Pradere; Jerome Le Pavec; Thibaut Pierre; Noémie Chanson; Jean-Yves Scoazec; Olivier Lambotte; Caroline Robert
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 3.  In-silico modeling of granulomatous diseases.

Authors:  Elliott D Crouser
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

Review 4.  Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Authors:  David R Moller; Ben A Rybicki; Nabeel Y Hamzeh; Courtney G Montgomery; Edward S Chen; Wonder Drake; Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 5.  Application of "Omics" and Systems Biology to Sarcoidosis Research.

Authors:  Elliott D Crouser; Tasha E Fingerlin; Ivana V Yang; Lisa A Maier; Patrick Nana-Sinkam; Ronald G Collman; Naftali Kaminski
Journal:  Ann Am Thorac Soc       Date:  2017-12

6.  Modeling Granulomas in Response to Infection in the Lung.

Authors:  Wenrui Hao; Larry S Schlesinger; Avner Friedman
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  Mathematical model on Alzheimer's disease.

Authors:  Wenrui Hao; Avner Friedman
Journal:  BMC Syst Biol       Date:  2016-11-18

8.  Exosomal miRs in Lung Cancer: A Mathematical Model.

Authors:  Xiulan Lai; Avner Friedman
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

9.  A Mathematical Model of Idiopathic Pulmonary Fibrosis.

Authors:  Wenrui Hao; Clay Marsh; Avner Friedman
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

10.  Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?

Authors:  Wing-Cheong Lo; Violeta Arsenescu; Razvan I Arsenescu; Avner Friedman
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.